glp 1 drugs type 1 diabetes on a GLP-1 Drug? Watch for Hypoglycemia and DKA GLP-1 receptor agonists are increasingly

The clinical impact of GLP-1 receptor agonists in type 2 diabetes: focus on the Long-Acting analogs

Gastric emptying in early noninsulin-dependent diabetes mellitus

I just dont quite know how smooth its going to be. In fall 2025, about 5 million US adults ages 65 and above the population that is covered by Medicare were taking a GLP-1 drug for weight loss or a chronic condition such as diabetes, according to a KFF Health survey

Nat Med 8:738742

This success in obesity treatment has naturally led researchers to explore their potential in other metabolic disorders, including liver diseases like MASH

These drugs mimic GLP-1 hormones naturally released in the body when eating